(Q41006417)

25 September 2017

1 reference

title

Pulmonary hypertension in chronic liver disease (English)

1 reference

25 September 2017

main subject

pulmonary hypertension

1 reference

inferred from title

chronic liver disease

0 references

author name string

Mandell MS

series ordinal

1

1 reference

25 September 2017

Groves BM

series ordinal

2

1 reference

25 September 2017

publication date

1 March 1996

1 reference

Clinics in Chest Medicine

25 September 2017

published in

1 reference

25 September 2017

volume

17

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

17-33

1 reference

Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part I: Primary pulmonary hypertension

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Characterization of thromboxane and prostacyclin effects on pulmonary vascular resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Effect of secretin on portal venous flow

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension complicating portal hypertension. A case report with suggestions for a different therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension. Case series from France

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

New therapies for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary Artery Hypertension Complicating Anesthesia for Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Laennec's cirrhosis and primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension: an unusual case associated with extrahepatic portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension. The American experience

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Right ventricular function during orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension and liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension and fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Coexistent pulmonary and portal hypertension: morphologic and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Clinical primary pulmonary hypertension: three pathologic types

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Vascular remodelling in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Dietary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

The emerging concept of vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Echocardiographic features of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

High cardiac output of advanced liver disease persists after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pathophysiology of pulmonary hypertension. A role for endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Coexistent pulmonary and portal hypertension: Yin and Yang

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary Hemodynamics in Primary Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary aspects of chronic liver disease and liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension and portal venous system thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Familial primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Progressive pulmonary hypertension in children with portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Nitric oxide reduces pulmonary hypertension during hepatic transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Progressive plexogenic pulmonary hypertension following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Comparison of Doppler-determined elevated pulmonary arterial pressure with pressure measured at cardiac catheterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Histometrical investigation of the pulmonary artery in severe hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension and cirrhosis: are they related?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Hypoxic Pulmonary Vasoconstriction in Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

"Primary" pulmonary hypertension with coexisting portal hypertension. A retrospective study of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Portosystemic Communications Studied by Transhepatic Portography

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension. Case series from the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary vasodilation with structurally altered pulmonary vessels and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Histopathology of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Nodular transformation of the liver associated with portal and pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Hemodynamic and metabolic changes in hepatic transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

The medical treatment of primary pulmonary hypertension. Proven and promising strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension. A national prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Antinuclear antibodies in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension with coexisting portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Factors that influence the outcome of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Plexogenic pulmonary arteriopathy and liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Primary pulmonary hypertension improved by long-term oral administration of nifedipine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension due to micro-thromboembolism from splenic and portal veins after portacaval anastomosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Porto-pulmonary venous anastomosis in portal hypertension demonstrated by percutaneous transhepatic cine-portography

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension complicating portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary hypertension associated with cirrhosis of the liver and with portacaval shunts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Hyperdynamic states and the physiologic determinants of survival in patients with cirrhosis and portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Association of Pulmonary Hypertension with Congenital Portal Hypertension in a Child

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Regulatory functions of the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Long-term hemodynamic effects of ketanserin, a 5-hydroxytryptamine blocker, in portal hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Transplantation of liver, heart, and lungs for primary biliary cirrhosis and primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Pulmonary endothelium-derived relaxing factor is impaired in hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Reversal of hypersplenism following orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970296-3

7 January 2021

10.1016/S0272-5231(05)70296-3

Identifiers

DOI

1 reference

25 September 2017

1 reference